{"id":33981,"date":"2025-11-19T03:03:18","date_gmt":"2025-11-19T03:03:18","guid":{"rendered":"https:\/\/metaverseplanet.net\/blog\/?p=33981"},"modified":"2026-01-07T09:19:03","modified_gmt":"2026-01-07T09:19:03","slug":"mit-invents-injectable-brain-chips","status":"publish","type":"post","link":"https:\/\/metaverseplanet.net\/blog\/mit-invents-injectable-brain-chips\/","title":{"rendered":"MIT Invents Injectable Brain Chips: A Surgery-Free Treatment Revolution"},"content":{"rendered":"\n

MIT is promising a new era in the treatment of neurological diseases<\/strong> by applying surgery-free electrical stimulation<\/strong> to brain<\/a><\/em> inflammation<\/strong> using wireless micro-implants<\/strong> that can be injected into the blood<\/strong>.<\/p>\n\n\n\n

A new biotechnology platform<\/strong> developed at MIT is introducing a treatment approach that could eliminate the need for surgeries<\/strong> requiring external intervention in the brain. The research team is working on wireless brain implants<\/strong> that can be injected<\/strong> into the body and self-navigate<\/strong> to the target area. This system, named \u201cCirculatronics<\/strong>,\u201d is described not as a classic brain chip, but as a holistic treatment infrastructure<\/strong> that can be transported to disease sites.<\/p>\n\n\n\n

\n\n\n\n

It Could Treat Neurological Diseases<\/h2>\n\n\n\n
\"\"<\/figure>\n\n\n\n

The MIT team, along with researchers from Wellesley College and Harvard University, describes the technology as a fully autonomous bioelectronic implant<\/strong>. The study is based on wireless electronic particles<\/strong>\u2014smaller even than a cell\u2014that can be administered into the bloodstream<\/strong>. These particles, called \u201cSWED<\/strong>\u201d (Sub-cellular Wireless Electronic Devices<\/strong>), form a hybrid structure<\/strong> by merging with immune cells<\/strong> (specifically monocytes<\/strong>) after injection. This allows them to follow the \u201cnatural cellular circulation<\/strong>\u201d and be transported to inflamed regions<\/strong> in the brain.<\/p>\n\n\n\n

Brain<\/a><\/em> inflammation<\/strong> plays a critical role at the root of many neurological diseases<\/strong>, from Alzheimer\u2019s<\/strong> and MS (Multiple Sclerosis)<\/strong> to stroke<\/strong> and brain tumors<\/strong>. When the SWEDs<\/strong> reach the target area, they settle into the relevant tissues and provide micro-level electrical stimulation<\/strong>. These stimulations aim to restore function to signals that are normally untransmittable. Researchers note that the method was successfully applied in rodent experiments<\/strong> and that the implants could be wirelessly controlled<\/strong> to provide electrical stimulation<\/strong> to neural tissue<\/strong>.<\/p>\n\n\n\n

\n\n\n\n

Clinical Trials 3 Years Away<\/h2>\n\n\n\n
\"\"<\/figure>\n\n\n\n

It is noted that it could take at least three years<\/strong> for this technology to be used in clinical trials<\/strong>. If the technology is successful, it may become possible to intervene in brain regions\u2014currently only accessible through high-risk surgeries<\/strong>\u2014in a surgery-free<\/strong>, low-cost<\/strong>, and much safer manner. The study’s lead researcher, Deblina Sarkar<\/strong>, emphasized that the limits of their approach are not confined to the brain<\/strong>, stating that electronic implants<\/strong> working with such biological carriers<\/strong> could be used in different parts of the body in the future.<\/p>\n\n\n\n

You Might Also Like;<\/h3>\n\n\n